COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA
Condition(s):Covid19Last Updated:July 20, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Covid19Last Updated:July 20, 2021Unknown status
Condition(s):Chronic Obstructive Pulmonary Disease; Altitude Sickness; Altitude HypoxiaLast Updated:March 3, 2023Active, not recruiting
Condition(s):Schizophrenic Disorder; Cognitive ImpairmentLast Updated:January 17, 2019Withdrawn
Condition(s):Lassa Virus InfectionLast Updated:February 21, 2023Recruiting
Condition(s):Lower Urinary Tract Symptoms; Bladder Carcinoma; BCGLast Updated:March 4, 2022Terminated
Condition(s):Cystic Fibrosis (CF)Last Updated:June 22, 2023Terminated
Condition(s):Right Heart Function; Chronic Obstructive Pulmonary Disease; Altitude SicknessLast Updated:November 2, 2022Recruiting
Condition(s):Hepatocellular Carcinoma; Tumor RecurrenceLast Updated:May 3, 2018Unknown status
Condition(s):Healthy Volunteers; Idiopathic Pulmonary FibrosisLast Updated:August 4, 2020Terminated
Condition(s):Stable Nonsegmental Vitiligo; Active Nonsegmental VitiligoLast Updated:February 5, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.